CASE REPORTS
JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

The malignant transformation of liver cell adenomas.

OBJECTIVE: To investigate clinical experience with the apparent malignant transformation of benign liver cell adenomas.

DESIGN: Retrospective review of personal experience and literature.

SETTING: University hospital and affilated community hospitals.

PATIENTS: All patients diagnosed with liver cell adenomas over a 30-year period.

INTERVENTIONS: Liver resection and/or tumor biopsy.

MAIN OUTCOME MEASURES: Gender, age, drug associations, alpha-fetoprotein levels, response to treatment, and survival.

RESULTS: Thirteen patients from personal experience and 26 patients from the reports of others had liver cell adenomas that were not resected. Five of these patients subsequently developed hepatocellular carcinoma.

CONCLUSIONS: Malignant transformation of a liver cell adenoma is a rare phenomenon, but it does occur. Alpha-fetoprotein levels may be more helpful in diagnosis than expected from previous reports. Solitary benign adenomas should be resected whenever possible. Patients with diffuse multiple tumors should be observed closely over a long period.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app